Pro-Dex, Inc. (PDEX) vs Stereotaxis Inc. (STXS)

Pro-Dex, Inc. and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Pro-Dex, Inc. is the larger, with a market value of $194.1M against $105.2M — 1.8× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 13.8×. Pro-Dex, Inc. grew revenue faster over the last twelve months: 16.5% against −5.46%. Pro-Dex, Inc. has the higher net margin (17.6% vs −78.5%) and the higher return on invested capital (15.8% vs −203.6%). Across the 19 metrics below, Pro-Dex, Inc. leads on 17 and Stereotaxis Inc. on 2.

Valuation

Metric PDEX STXS Medical Instruments & Supplies median
P/E 13.77 n/m 33.75
P/S 2.42 3.36 2.52
P/B 3.95 8.25 2.48
Price to free cash flow 27.94 n/m 25.19
EV/EBITDA 13.33 n/m 14.62
EV/Sales 2.47 3.12 2.88
Earnings yield 7.26% (23.76%) (2.67%)
Free cash flow yield 3.58% (15.34%) 0.09%

Profitability

Metric PDEX STXS Medical Instruments & Supplies median
Gross margin 31.38% 55.57% 54.29%
Operating margin 16.75% (75.68%) 1.07%
Net margin 17.62% (78.45%) (1.61%)
Free cash flow margin 8.72% (51.56%) 1.08%
Return on equity 32.43% (344.36%) (1.32%)
Return on assets 20.14% (48.76%) 0.00%
Return on invested capital 15.75% (203.58%) 0.00%

Growth

Metric PDEX STXS Medical Instruments & Supplies median
Revenue growth (TTM) 16.45% (5.46%) 8.85%
EPS growth (last fiscal year) 54.31% 16.67% 8.65%
Revenue growth, 5-year CAGR 15.32% 3.99% 9.17%
Net income growth, 5-year CAGR 17.23% 0.00% 0.00%

Health

Metric PDEX STXS Medical Instruments & Supplies median
Debt to equity 0.28 0.00 0.10
Current ratio 4.10 1.42 2.48
Net debt to EBITDA 0.27 0.65 0.89

Dividend

Metric PDEX STXS Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric PDEX STXS Medical Instruments & Supplies median
Market cap 194.06m 105.21m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack